Diagnostic Imaging's Weekly Scan: October 8-October 14

News
Slideshow

Catch up on the top radiology content of the past week.

Diagnostic Imaging's Weekly Scan is your chance to catch up on the latest radiology content, from new research and device news to the latest case quizzes and conference reports. Review the slideshow below to see this week's top content:

Recent Videos
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Related Content
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?

Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?

Jeff Hall
April 4th 2025
Article

Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS

Jeff Hall
April 1st 2025
Article

New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

Are CT and MRI-Derived LI-RADS Assessments Effective for Detecting HCC in Cases of Non-Cirrhotic Chronic Hepatitis C?

Are CT and MRI-Derived LI-RADS Assessments Effective for Detecting HCC in Cases of Non-Cirrhotic Chronic Hepatitis C?

Jeff Hall
March 31st 2025
Article

LI-RADS category 5 (LR-5) assessment had an 11 percent higher AUC for detecting hepatocellular carcinoma (HCC) in patients with non-cirrhotic chronic hepatitis C (CHC) in comparison to those with cirrhotic CHC.

Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC

Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC

Jeff Hall
March 28th 2025
Article

Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).

© 2025 MJH Life Sciences

All rights reserved.